https://www.selleckchem.com/CDK.html
and non-typeable (NT ) are substantial contributors to morbidity and mortality of diseases including invasive pneumococcal diseases (IPDs), pneumonia and acute otitis media (AOM) worldwide. In Taiwan, 10-valent pneumococcal polysaccharide and NT protein D conjugate vaccine (PHiD-CV) and 13-valent pneumococcal conjugate vaccine (PCV13) are licensed in children against pneumococcal disease. In addition to , clinical trials suggest efficacy of PHiD-CV against NT AOM. This study aims at evaluating the cost-effectiveness of a 2 + 1 schedule of PHiD-CV vs
Like
Comment
Share
